

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 5.27700437 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.27700437 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.27700437 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.27700437 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.27700437 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.27700437 |
| 7 | response to peptidoglycan (GO:0032494) | 5.15095014 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 4.97198889 |
| 9 | * positive regulation of gamma-delta T cell activation (GO:0046645) | 4.95173604 |
| 10 | * negative regulation of interleukin-12 production (GO:0032695) | 4.86422736 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 4.70155361 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.39123485 |
| 13 | * negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.12681179 |
| 14 | * negative regulation of cell killing (GO:0031342) | 4.12681179 |
| 15 | cellular response to type I interferon (GO:0071357) | 4.08476458 |
| 16 | type I interferon signaling pathway (GO:0060337) | 4.08476458 |
| 17 | detection of other organism (GO:0098543) | 4.06810790 |
| 18 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.06310963 |
| 19 | response to type I interferon (GO:0034340) | 4.06222333 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.06089122 |
| 21 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.02027717 |
| 22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.98796955 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.98482762 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.96143655 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.95468460 |
| 26 | detection of bacterium (GO:0016045) | 3.92009877 |
| 27 | defense response to protozoan (GO:0042832) | 3.88497818 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.88333639 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.85700954 |
| 30 | regulation of antigen processing and presentation (GO:0002577) | 3.85401479 |
| 31 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.83010797 |
| 32 | T-helper 1 type immune response (GO:0042088) | 3.75405303 |
| 33 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.70943984 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.67154236 |
| 35 | response to protozoan (GO:0001562) | 3.66421499 |
| 36 | detection of molecule of bacterial origin (GO:0032490) | 3.65341023 |
| 37 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.65292493 |
| 38 | B cell mediated immunity (GO:0019724) | 3.63506207 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.62636215 |
| 40 | response to host immune response (GO:0052572) | 3.62636215 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.62075811 |
| 42 | microglial cell activation (GO:0001774) | 3.61144630 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.59325865 |
| 44 | germinal center formation (GO:0002467) | 3.57385621 |
| 45 | T cell migration (GO:0072678) | 3.54677965 |
| 46 | positive regulation of type 2 immune response (GO:0002830) | 3.52539906 |
| 47 | detection of external biotic stimulus (GO:0098581) | 3.51876068 |
| 48 | response to muramyl dipeptide (GO:0032495) | 3.49518534 |
| 49 | cellular extravasation (GO:0045123) | 3.49224993 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 3.48493741 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 3.48376971 |
| 52 | positive regulation of interferon-alpha production (GO:0032727) | 3.48044116 |
| 53 | myeloid cell activation involved in immune response (GO:0002275) | 3.46772500 |
| 54 | macrophage activation (GO:0042116) | 3.43488963 |
| 55 | granulocyte activation (GO:0036230) | 3.37983630 |
| 56 | * regulation of gamma-delta T cell activation (GO:0046643) | 3.36840098 |
| 57 | leukocyte aggregation (GO:0070486) | 3.34308933 |
| 58 | neutrophil activation (GO:0042119) | 3.30329108 |
| 59 | respiratory burst (GO:0045730) | 3.26944022 |
| 60 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.26125280 |
| 61 | regulation of tolerance induction (GO:0002643) | 3.24731985 |
| 62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.24101689 |
| 63 | response to host (GO:0075136) | 3.24101689 |
| 64 | response to host defenses (GO:0052200) | 3.24101689 |
| 65 | myeloid dendritic cell differentiation (GO:0043011) | 3.18849857 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 3.18718378 |
| 67 | cellular response to interferon-gamma (GO:0071346) | 3.17977008 |
| 68 | detection of biotic stimulus (GO:0009595) | 3.17566123 |
| 69 | positive regulation of mast cell activation (GO:0033005) | 3.15419953 |
| 70 | B cell receptor signaling pathway (GO:0050853) | 3.06577349 |
| 71 | regulation of mast cell activation (GO:0033003) | 3.05499259 |
| 72 | myeloid dendritic cell activation (GO:0001773) | 3.05111765 |
| 73 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.04570493 |
| 74 | * regulation of interleukin-12 production (GO:0032655) | 3.03944826 |
| 75 | response to interferon-gamma (GO:0034341) | 2.99224411 |
| 76 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.96342539 |
| 77 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.95808166 |
| 78 | * regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.95465151 |
| 79 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.94916330 |
| 80 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.94869188 |
| 81 | positive regulation of B cell differentiation (GO:0045579) | 2.94297518 |
| 82 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.93153032 |
| 83 | positive regulation of interferon-beta production (GO:0032728) | 2.92979939 |
| 84 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91190628 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.87746507 |
| 86 | regulation of type 2 immune response (GO:0002828) | 2.86400410 |
| 87 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.85645540 |
| 88 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.84254608 |
| 89 | positive regulation of B cell mediated immunity (GO:0002714) | 2.84254608 |
| 90 | regulation of podosome assembly (GO:0071801) | 2.84119275 |
| 91 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.83996973 |
| 92 | positive regulation of tolerance induction (GO:0002645) | 2.83096374 |
| 93 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.82817644 |
| 94 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.80407385 |
| 95 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.80246026 |
| 96 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.79904719 |
| 97 | myeloid leukocyte activation (GO:0002274) | 2.79695077 |
| 98 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.78717578 |
| 99 | * negative regulation of cytokine production involved in immune response (GO:0002719) | 2.78619959 |
| 100 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77724357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.13201566 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.23471188 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.59017101 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.03165775 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.85457746 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.78105154 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.63713869 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.59716212 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.40654172 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25637216 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05429329 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.91982457 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.72337755 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72294820 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70697159 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.65920494 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.62700907 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.45327330 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.41663498 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.41208340 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.40588660 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33972048 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.32840338 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.30374782 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24059214 |
| 26 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.19069466 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18487229 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.13383238 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 2.11582422 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.04261406 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03765180 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97824714 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.86886877 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.83272326 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83017956 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75843834 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.73612454 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69911050 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68245432 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63401175 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63003550 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60899732 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55899445 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55477973 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53131606 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48675413 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47920792 |
| 48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47105341 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43781753 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.43597616 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36874959 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36264934 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35391934 |
| 54 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.34204879 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34137346 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32661851 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32071872 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31811773 |
| 59 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30850225 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26891172 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24802461 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24764545 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24531940 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24326223 |
| 65 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23934609 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22997811 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20586095 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19071768 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16959147 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15839720 |
| 71 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14046576 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11155517 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10683479 |
| 74 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04788986 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04670663 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04328165 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03420150 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03100869 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02747670 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01393800 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99186792 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99083707 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97149055 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96903746 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96719840 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93798293 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91719158 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90919210 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90569170 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90042878 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87934615 |
| 92 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84331993 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.77813061 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.74047480 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71947256 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.70792655 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.70208955 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67049650 |
| 99 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.64907137 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.63404220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.68186466 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.06147603 |
| 3 | MP0003724_increased_susceptibility_to | 3.85840300 |
| 4 | MP0003436_decreased_susceptibility_to | 3.77675542 |
| 5 | MP0005671_abnormal_response_to | 3.51647757 |
| 6 | MP0009785_altered_susceptibility_to | 3.40614503 |
| 7 | MP0005387_immune_system_phenotype | 3.32949271 |
| 8 | MP0001790_abnormal_immune_system | 3.32949271 |
| 9 | MP0006082_CNS_inflammation | 3.18965914 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 3.17317510 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.14399024 |
| 12 | MP0000685_abnormal_immune_system | 3.05935873 |
| 13 | MP0002419_abnormal_innate_immunity | 2.96286602 |
| 14 | MP0001800_abnormal_humoral_immune | 2.95958957 |
| 15 | MP0005025_abnormal_response_to | 2.86228667 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.67724981 |
| 17 | MP0002723_abnormal_immune_serum | 2.66427884 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.43302150 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.35337111 |
| 20 | MP0001819_abnormal_immune_cell | 2.34170121 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.17474858 |
| 22 | MP0004510_myositis | 2.13964487 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.04876750 |
| 24 | MP0009764_decreased_sensitivity_to | 2.03381862 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.99772763 |
| 26 | MP0001845_abnormal_inflammatory_respons | 1.92793969 |
| 27 | MP0002405_respiratory_system_inflammati | 1.88257099 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.85843785 |
| 29 | MP0009278_abnormal_bone_marrow | 1.79039401 |
| 30 | MP0004947_skin_inflammation | 1.78290852 |
| 31 | MP0000716_abnormal_immune_system | 1.74419696 |
| 32 | MP0005310_abnormal_salivary_gland | 1.71930532 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.71204967 |
| 34 | MP0003075_altered_response_to | 1.70267705 |
| 35 | MP0008469_abnormal_protein_level | 1.64397587 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.63022415 |
| 37 | MP0002398_abnormal_bone_marrow | 1.61675625 |
| 38 | MP0000343_altered_response_to | 1.57386698 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.54483027 |
| 40 | MP0009840_abnormal_foam_cell | 1.53768182 |
| 41 | MP0001853_heart_inflammation | 1.45618761 |
| 42 | MP0005451_abnormal_body_composition | 1.45160533 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.43578971 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.40765790 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.40765790 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.40132081 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.39976559 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.39887752 |
| 49 | MP0002429_abnormal_blood_cell | 1.34558439 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.34467258 |
| 51 | MP0000604_amyloidosis | 1.33567402 |
| 52 | MP0003690_abnormal_glial_cell | 1.27995019 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 1.27533255 |
| 54 | MP0002722_abnormal_immune_system | 1.27255347 |
| 55 | MP0000858_altered_metastatic_potential | 1.23112731 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.20505599 |
| 57 | MP0005166_decreased_susceptibility_to | 1.20015781 |
| 58 | MP0008004_abnormal_stomach_pH | 1.17811586 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.16152377 |
| 60 | MP0008260_abnormal_autophagy | 1.15787412 |
| 61 | MP0003448_altered_tumor_morphology | 1.15089089 |
| 62 | MP0002254_reproductive_system_inflammat | 1.14138792 |
| 63 | MP0003828_pulmonary_edema | 1.07360817 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.00173061 |
| 65 | MP0004883_abnormal_blood_vessel | 0.97558754 |
| 66 | MP0009763_increased_sensitivity_to | 0.95628645 |
| 67 | MP0001873_stomach_inflammation | 0.95066074 |
| 68 | MP0001663_abnormal_digestive_system | 0.94180406 |
| 69 | MP0002332_abnormal_exercise_endurance | 0.92795536 |
| 70 | MP0005164_abnormal_response_to | 0.90347837 |
| 71 | MP0000703_abnormal_thymus_morphology | 0.86728390 |
| 72 | MP0003866_abnormal_defecation | 0.86099139 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.84536262 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 0.84028355 |
| 75 | MP0003195_calcinosis | 0.83884458 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.79742295 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.78541800 |
| 78 | MP0005390_skeleton_phenotype | 0.78525852 |
| 79 | MP0002933_joint_inflammation | 0.73848184 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.73279241 |
| 81 | MP0001851_eye_inflammation | 0.71397126 |
| 82 | MP0006054_spinal_hemorrhage | 0.70728775 |
| 83 | MP0002006_tumorigenesis | 0.70415213 |
| 84 | MP0008874_decreased_physiological_sensi | 0.69464793 |
| 85 | MP0000920_abnormal_myelination | 0.66766402 |
| 86 | MP0003091_abnormal_cell_migration | 0.66551475 |
| 87 | MP0000249_abnormal_blood_vessel | 0.64866185 |
| 88 | MP0003045_fibrosis | 0.64781522 |
| 89 | MP0003795_abnormal_bone_structure | 0.64136601 |
| 90 | MP0002693_abnormal_pancreas_physiology | 0.63945413 |
| 91 | MP0002132_abnormal_respiratory_system | 0.62434819 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 0.62364546 |
| 93 | MP0000371_diluted_coat_color | 0.61969131 |
| 94 | MP0003646_muscle_fatigue | 0.58999246 |
| 95 | MP0005535_abnormal_body_temperature | 0.50581669 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.50468198 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.49892135 |
| 98 | MP0000609_abnormal_liver_physiology | 0.48494661 |
| 99 | MP0000490_abnormal_crypts_of | 0.48030584 |
| 100 | MP0001501_abnormal_sleep_pattern | 0.47944152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.76615889 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.54402589 |
| 3 | Abnormality of macrophages (HP:0004311) | 5.49615859 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.42997546 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 5.19381379 |
| 6 | Optic neuritis (HP:0100653) | 5.19381379 |
| 7 | Orchitis (HP:0100796) | 5.10347315 |
| 8 | Myositis (HP:0100614) | 5.02759513 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.67806939 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.67806939 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.67806939 |
| 12 | Stomatitis (HP:0010280) | 4.53875588 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.46269620 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.31081644 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.93470401 |
| 16 | Vasculitis (HP:0002633) | 3.81076097 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.80541366 |
| 18 | Meningitis (HP:0001287) | 3.78119633 |
| 19 | Recurrent skin infections (HP:0001581) | 3.77160365 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.65288969 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 3.53918691 |
| 22 | Recurrent viral infections (HP:0004429) | 3.44294477 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.43553401 |
| 24 | Obstructive lung disease (HP:0006536) | 3.43545149 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.43545149 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.40542348 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.40542348 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.38677879 |
| 29 | Encephalitis (HP:0002383) | 3.35231708 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.33012666 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 3.26835544 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.25674599 |
| 33 | Hemoptysis (HP:0002105) | 3.25374512 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 3.19694116 |
| 35 | Loss of speech (HP:0002371) | 3.13784786 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 3.05416232 |
| 37 | Dysostosis multiplex (HP:0000943) | 3.01562614 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.00076671 |
| 39 | Gastrointestinal stroma tumor (HP:0100723) | 2.97200753 |
| 40 | Increased IgE level (HP:0003212) | 2.96414118 |
| 41 | Increased IgM level (HP:0003496) | 2.95572725 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.94885735 |
| 43 | Urticaria (HP:0001025) | 2.89883353 |
| 44 | T lymphocytopenia (HP:0005403) | 2.84248700 |
| 45 | Disinhibition (HP:0000734) | 2.83909535 |
| 46 | Gingivitis (HP:0000230) | 2.82659453 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.75639355 |
| 48 | Hematochezia (HP:0002573) | 2.67012256 |
| 49 | Leukocytosis (HP:0001974) | 2.66791536 |
| 50 | Colitis (HP:0002583) | 2.65430320 |
| 51 | Gangrene (HP:0100758) | 2.64827054 |
| 52 | Mutism (HP:0002300) | 2.64700859 |
| 53 | Increased serum ferritin (HP:0003281) | 2.64026991 |
| 54 | Arterial thrombosis (HP:0004420) | 2.63694431 |
| 55 | Cellulitis (HP:0100658) | 2.60374764 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.60297705 |
| 57 | Lymphopenia (HP:0001888) | 2.57730059 |
| 58 | Agammaglobulinemia (HP:0004432) | 2.50677146 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.48585309 |
| 60 | Chest pain (HP:0100749) | 2.47468900 |
| 61 | Amyloidosis (HP:0011034) | 2.47296022 |
| 62 | Anorexia (HP:0002039) | 2.44851592 |
| 63 | Pulmonary embolism (HP:0002204) | 2.44696475 |
| 64 | Abnormality of the pleura (HP:0002103) | 2.43147934 |
| 65 | Petechiae (HP:0000967) | 2.40724673 |
| 66 | Purpura (HP:0000979) | 2.38877803 |
| 67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.38620916 |
| 68 | Hypergammaglobulinemia (HP:0010702) | 2.36559584 |
| 69 | Gastrointestinal inflammation (HP:0004386) | 2.34509125 |
| 70 | Glomerulonephritis (HP:0000099) | 2.33886916 |
| 71 | Polyneuropathy (HP:0001271) | 2.33837033 |
| 72 | Chronic otitis media (HP:0000389) | 2.33077065 |
| 73 | Restrictive lung disease (HP:0002091) | 2.32859468 |
| 74 | Abnormality of T cells (HP:0002843) | 2.30686270 |
| 75 | Recurrent bronchitis (HP:0002837) | 2.26811853 |
| 76 | Recurrent sinusitis (HP:0011108) | 2.26515765 |
| 77 | Osteomyelitis (HP:0002754) | 2.26341422 |
| 78 | Abnormality of iron homeostasis (HP:0011031) | 2.26071257 |
| 79 | Recurrent pneumonia (HP:0006532) | 2.24632251 |
| 80 | Pustule (HP:0200039) | 2.22615403 |
| 81 | Episodic fever (HP:0001954) | 2.22296914 |
| 82 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22271181 |
| 83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22271181 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22271181 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17898212 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.12882221 |
| 87 | Epistaxis (HP:0000421) | 2.11586951 |
| 88 | Autoimmune hemolytic anemia (HP:0001890) | 2.10904976 |
| 89 | Premature loss of primary teeth (HP:0006323) | 2.10546517 |
| 90 | Arthralgia (HP:0002829) | 2.09147421 |
| 91 | Gingival bleeding (HP:0000225) | 2.07919191 |
| 92 | Granulocytopenia (HP:0001913) | 2.07649096 |
| 93 | Vertigo (HP:0002321) | 2.07077128 |
| 94 | Malnutrition (HP:0004395) | 2.07050896 |
| 95 | Sepsis (HP:0100806) | 2.05060871 |
| 96 | IgA deficiency (HP:0002720) | 2.04649187 |
| 97 | Mucopolysacchariduria (HP:0008155) | 2.02728463 |
| 98 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02728463 |
| 99 | Abnormality of the endocardium (HP:0004306) | 2.02630215 |
| 100 | Joint swelling (HP:0001386) | 2.00470690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.55962805 |
| 2 | MAP4K1 | 3.67756247 |
| 3 | BLK | 3.52277288 |
| 4 | TYK2 | 3.14478094 |
| 5 | MAP3K14 | 3.06624491 |
| 6 | IRAK4 | 2.85689593 |
| 7 | IRAK3 | 2.73967100 |
| 8 | CSK | 2.57053584 |
| 9 | PRPF4B | 2.41513853 |
| 10 | MATK | 2.33165538 |
| 11 | TBK1 | 2.30422671 |
| 12 | IKBKE | 2.28215343 |
| 13 | FGR | 2.23770793 |
| 14 | JAK3 | 2.09117662 |
| 15 | ERN1 | 2.09050720 |
| 16 | TXK | 2.00678895 |
| 17 | MAP3K13 | 1.97924273 |
| 18 | GRK7 | 1.97272507 |
| 19 | IKBKB | 1.92649077 |
| 20 | SYK | 1.85735628 |
| 21 | JAK1 | 1.74970195 |
| 22 | MAP2K3 | 1.69655409 |
| 23 | CSF1R | 1.68681082 |
| 24 | BMPR2 | 1.64583016 |
| 25 | FES | 1.58647439 |
| 26 | MAP3K11 | 1.55893623 |
| 27 | LYN | 1.51875315 |
| 28 | BTK | 1.51260837 |
| 29 | ZAP70 | 1.46119406 |
| 30 | KIT | 1.45412548 |
| 31 | TAOK2 | 1.43661824 |
| 32 | TNK2 | 1.41298862 |
| 33 | NME2 | 1.40779664 |
| 34 | CDC42BPA | 1.38527185 |
| 35 | DDR2 | 1.38326690 |
| 36 | TAOK1 | 1.35630101 |
| 37 | TAOK3 | 1.34834956 |
| 38 | SIK3 | 1.28597487 |
| 39 | MAP3K3 | 1.28374515 |
| 40 | HCK | 1.27959909 |
| 41 | JAK2 | 1.21091119 |
| 42 | TGFBR2 | 1.20794524 |
| 43 | SIK2 | 1.16466859 |
| 44 | MARK3 | 1.13255036 |
| 45 | IRAK1 | 1.12984570 |
| 46 | LCK | 1.11844315 |
| 47 | CHUK | 0.99204282 |
| 48 | ADRBK2 | 0.98505789 |
| 49 | MAP3K1 | 0.95773890 |
| 50 | ITK | 0.88590037 |
| 51 | ACVR1B | 0.88205211 |
| 52 | IRAK2 | 0.86961173 |
| 53 | MOS | 0.84926525 |
| 54 | TEC | 0.84159579 |
| 55 | GRK6 | 0.77304379 |
| 56 | STK10 | 0.76815508 |
| 57 | EPHB1 | 0.73408263 |
| 58 | PDK1 | 0.73034328 |
| 59 | MAPK7 | 0.66182994 |
| 60 | PRKCQ | 0.59860897 |
| 61 | MAP3K5 | 0.59738562 |
| 62 | CAMKK2 | 0.59267060 |
| 63 | PIM1 | 0.59108289 |
| 64 | EPHA3 | 0.58068669 |
| 65 | FGFR4 | 0.57608255 |
| 66 | DAPK2 | 0.56390232 |
| 67 | PDPK1 | 0.54859567 |
| 68 | HIPK2 | 0.51754462 |
| 69 | FGFR3 | 0.51558274 |
| 70 | TYRO3 | 0.51296749 |
| 71 | NEK9 | 0.51070890 |
| 72 | YES1 | 0.48168098 |
| 73 | FYN | 0.44824547 |
| 74 | PRKD2 | 0.44721152 |
| 75 | MAPK12 | 0.43296437 |
| 76 | MARK2 | 0.43001105 |
| 77 | ABL1 | 0.40423594 |
| 78 | RPS6KL1 | 0.39139136 |
| 79 | RPS6KC1 | 0.39139136 |
| 80 | KSR2 | 0.39112440 |
| 81 | PIM2 | 0.37350226 |
| 82 | MAP2K6 | 0.36181687 |
| 83 | RPS6KA6 | 0.35627064 |
| 84 | TESK2 | 0.33351749 |
| 85 | MAPK4 | 0.32471956 |
| 86 | CDK4 | 0.27708806 |
| 87 | PRKCD | 0.27328556 |
| 88 | INSR | 0.26831181 |
| 89 | RIPK1 | 0.26490340 |
| 90 | MAPKAPK2 | 0.26256441 |
| 91 | CAMKK1 | 0.25212848 |
| 92 | MAPK11 | 0.24655175 |
| 93 | SGK3 | 0.23329638 |
| 94 | SIK1 | 0.21935602 |
| 95 | EGFR | 0.21876227 |
| 96 | CAMK1D | 0.21555813 |
| 97 | ARAF | 0.20382201 |
| 98 | CDK6 | 0.20074320 |
| 99 | STK11 | 0.19669387 |
| 100 | STK24 | 0.19338304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.32687625 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.12205836 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.01418755 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.00326229 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.92090516 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.84522895 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.83645288 |
| 8 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.74175148 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.52919480 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.51818543 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.50973762 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.26807578 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.26676546 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.18914575 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.15962188 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.10139919 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02745476 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98299928 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90518384 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.87189060 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.79694089 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.76758858 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74894208 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.73212882 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.71520154 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69108162 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66762789 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.62539897 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.59932382 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53619445 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.52275316 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46767770 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.44118410 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42701879 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39294390 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38099805 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37271274 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36564219 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.35970650 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24260513 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22169741 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20271053 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15512552 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.14623641 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.08133816 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.06778691 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02309103 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98309365 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89911615 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88883838 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.86063942 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83213399 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83038679 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.82477940 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75436191 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66516614 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66462511 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63341884 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.61684391 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54542150 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53017529 |
| 62 | Prion diseases_Homo sapiens_hsa05020 | 0.52859754 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.51620818 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49097826 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48259482 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47644220 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47166305 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46587874 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46189064 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.45663540 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44683593 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43662976 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42254591 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39711850 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39374282 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37643443 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37319372 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35295610 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34757448 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32234290 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32200834 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30582578 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30171758 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29697469 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.28356678 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28142354 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28108352 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26115325 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25821110 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.25071914 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22560299 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.21760518 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20333673 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.13121312 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10583997 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.09282349 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.09191043 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.08803656 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.05691624 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.05030136 |

